News

Pharmabiz2h
AusperBio gets China CDE clearance to initiate phase III clinical trial of AHB-137 for chronic hepatitis B
AusperBio gets China CDE clearance to initiate phase III clinical trial of AHB-137 for chronic hepatitis B: San Francisco Wednesday, July 23, 2025, 18:00 Hrs [IST] AusperBio Thera ...
Pharmabiz3h
Medical Parliamentarians call for urgent action against growing burden of stroke
The Indian Medical Parliamentarians Forum (IMPF), a cross-party platform of medical professionals in the Parliament, has called for comprehensive and urgent action to address the growing burden of ...
Pharmabiz4h
Cycle Pharma enters exclusive US commercialization agreement with Handa for Phyrago to treat two types of leukaemia, Ph+ CML & Ph+ ALL
Cycle Pharma enters exclusive US commercialization agreement with Handa for Phyrago to treat two types of leukaemia, Ph+ CML & Ph+ ALL: Cambridge, UK Wednesday, July 23, 2025, 16: ...
Pharmabiz4h
Dr Rajesh Venkat Indala, Apollo Hospitals, Vizag neurologist honoured as Fellow of the American Academy of Neurology
Dr Rajesh Venkat Indala, Apollo Hospitals, Vizag neurologist honoured as Fellow of the American Academy of Neurology: Our Bureau, Mumbai Wednesday, July 23, 2025, 15:45 Hrs [IST] ...
Pharmabiz4h
Biocon Biologics appoints Deepali Naair as global head - brand & corporate communications
Biocon Biologics appoints Deepali Naair as global head - brand & corporate communications: Our Bureau, Bengaluru Wednesday, July 23, 2025, 15:15 Hrs [IST] Biocon Biologics has app ...
Pharmabiz5h
US FDA grants fast track designation to DualityBio's next-generation HER3 ADC DB-1310 to treat nonsquamous non-small cell lung cancer
US FDA grants fast track designation to DualityBio's next-generation HER3 ADC DB-1310 to treat nonsquamous non-small cell lung cancer: Shanghai Wednesday, July 23, 2025, 14:30 Hrs ...
Pharmabiz6h
Spirair receives US FDA clearance for TurbAlign, a new bioabsorbable implant that helps keep nasal passages open after sinus surgery
Spirair receives US FDA clearance for TurbAlign, a new bioabsorbable implant that helps keep nasal passages open after sinus surgery: South San Francisco Wednesday, July 23, 2025, ...
Pharmabiz6h
Centre screens six crore individuals for sickle cell disease
The Central government has said that it has conducted screening of a total of six crore individuals for sickle cell disease (SCD) against the targeted seven crore under the National Sickle Cell ...
Pharmabiz7h
WuXi Biologics secures US FDA Pre-License Inspection approval for five facilities, first for commercial PFS line
WuXi Biologics secures US FDA Pre-License Inspection approval for five facilities, first for commercial PFS line: Wuxi, China Wednesday, July 23, 2025, 13:00 Hrs [IST] WuXi Biolog ...
Pharmabiz7h
Centre approved 48 projects under PLI Scheme for bulk drugs, says Minister
Centre approved 48 projects under PLI Scheme for bulk drugs, says Minister: Our Bureau, New Delhi Wednesday, July 23, 2025, 12:45 Hrs [IST] The Central government has said that it ...
Pharmabiz7h
Centre expects to exceed target sales under PLI scheme for pharma in fourth year
Centre expects to exceed target sales under PLI scheme for pharma in fourth year: Our Bureau, New Delhi Wednesday, July 23, 2025, 12:20 Hrs [IST] The Central government is expecti ...
Pharmabiz8h
Sarepta Therapeutics announces voluntary pause all shipments of Elevidys for Duchenne muscular dystrophy in US
Sarepta Therapeutics announces voluntary pause all shipments of Elevidys for Duchenne muscular dystrophy in US: Cambridge, Massachusetts Wednesday, July 23, 2025, 12:00 Hrs [IST] ...